Legislation Details

File #: 24-1817    Version: 1
Type: Executive Session Status: Agenda Ready
File created: 7/30/2024 In control: City Council
On agenda: 8/13/2024 Final action:
Title: Pursuant to Section 307B.4, Title 25, Oklahoma Statutes, consider convening in executive session to discuss an action relating to litigation against the manufacturers and distributors of opioids in an effort to hold them accountable for their marketing practices alleged to have caused damages suffered by municipalities, specifically, the City’s pending litigation as part of In Re: National Prescription Opiate Litigation MDL No. 2804, and if necessary, take action in open session.
Date Ver.Action ByActionResultAction DetailsMeeting DetailsVideo
No records to display.

ITEM TITLE:

 

Pursuant to Section 307B.4, Title 25, Oklahoma Statutes, consider convening in executive session to discuss an action relating to litigation against the manufacturers and distributors of opioids in an effort to hold them accountable for their marketing practices alleged to have caused damages suffered by municipalities, specifically, the City’s pending litigation as part of In Re: National Prescription Opiate Litigation MDL No. 2804, and if necessary, take action in open session.

 

INITIATOR:  John Andrew, City Attorney

 

STAFF INFORMATION SOURCE:  John Andrew, City Attorney; Timothy Wilson, Deputy City Attorney

 

BACKGROUND: The City Attorney desires to discuss with the Mayor and Council its ongoing opioid litigation and, if necessary, take action in open session. The City Attorney advises the City Council that the Council should determine that disclosure of confidential communication between the Council and the City Attorney regarding the above referenced action will seriously impair the ability of the City Attorney to protect the City’s interest, and from that determination, the Council should convene in executive session to discuss this matter.

 

EXHIBIT:  N/A

 

KEY ISSUES:  N/A

 

FUNDING SOURCE:  N/A

 

STAFF RECOMMENDED COUNCIL ACTION:  Convene in executive session to discuss an action against the manufacturers and distributors of opioids in an effort to hold them accountable for their marketing practices alleged to have caused damages suffered by municipalities, and if necessary, take action in open session.